Overview

A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

Status:
NOT_YET_RECRUITING
Trial end date:
2029-02-21
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of 608 in patients with nr-axSpA.
Phase:
PHASE3
Details
Lead Sponsor:
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.